This became clear during the assessment of the HRQoL and during literature search
Kirkland, A
H., Zhang, L., Kremer, D., Hwang, R
Precedent: CagriSema Success Supports Combination Approach The strongest evidence supporting a cagrilintide blend with retatrutide comes from Novo Nordisk's CagriSema program, which combines cagrilintide with semaglutide (a GLP-1 receptor agonist)
For those who dont know, free radicals are basically unstable molecules that cause oxidative stress, speeding up ageing and contributing to things such as our susceptibility to inflammation and disease
Monitoring your progress through periodic liver function tests, typically every 3-6 months when actively supplementing, provides objective data to guide dosage adjustments and confirm that supplementation is benefiting your liver health